Shealy D - Search Results

1

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.

Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, Li L. Yang G, et al. Among authors: shealy d. Cytokine. 2004 Dec 21;28(6):224-32. doi: 10.1016/j.cyto.2004.08.007. Cytokine. 2004. PMID: 15566951

2

Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice.

Shealy DJ, Wooley PH, Emmell E, Volk A, Rosenberg A, Treacy G, Wagner CL, Mayton L, Griswold DE, Song XY. Shealy DJ, et al. Arthritis Res. 2002;4(5):R7. doi: 10.1186/ar430. Epub 2002 Jun 28. Arthritis Res. 2002. PMID: 12223110 Free PMC article.

3

Induction of dendritic cell maturation by IL-18.

Li J, Mbow ML, Sun L, Li L, Yang G, Griswold DE, Schantz A, Shealy DJ, Goletz TJ, Wan J, Peritt D. Li J, et al. Among authors: shealy dj. Cell Immunol. 2004 Feb;227(2):103-8. doi: 10.1016/j.cellimm.2004.02.002. Cell Immunol. 2004. PMID: 15135292

4

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.

Shealy DJ, Cai A, Staquet K, Baker A, Lacy ER, Johns L, Vafa O, Gunn G 3rd, Tam S, Sague S, Wang D, Brigham-Burke M, Dalmonte P, Emmell E, Pikounis B, Bugelski PJ, Zhou H, Scallon BJ, Giles-Komar J. Shealy DJ, et al. MAbs. 2010 Jul-Aug;2(4):428-39. doi: 10.4161/mabs.12304. Epub 2010 Jul 1. MAbs. 2010. PMID: 20519961 Free PMC article.

5

Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders.

Benson JM, Peritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, Mascelli MA. Benson JM, et al. Among authors: shealy dj. MAbs. 2011 Nov-Dec;3(6):535-45. doi: 10.4161/mabs.3.6.17815. Epub 2011 Nov 1. MAbs. 2011. PMID: 22123062 Free PMC article. Review.

6

Coming of age: anti-cytokine therapies.

Song XY, Torphy TJ, Griswold DE, Shealy D. Song XY, et al. Among authors: shealy d. Mol Interv. 2002 Feb;2(1):36-46. doi: 10.1124/mi.2.1.36. Mol Interv. 2002. PMID: 14993360 Review.

7

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

Siegel SA, Shealy DJ, Nakada MT, Le J, Woulfe DS, Probert L, Kollias G, Ghrayeb J, Vilcek J, Daddona PE. Siegel SA, et al. Among authors: shealy dj. Cytokine. 1995 Jan;7(1):15-25. doi: 10.1006/cyto.1995.1003. Cytokine. 1995. PMID: 7538333 Free article.

8

Identification of TNF-alpha binding peptides from a D-amino acid hexapeptide library that specifically inhibit TNF-alpha binding to recombinant p55 receptor.

Kruszynski M, Shealy DJ, Leone AO, Heavner GA. Kruszynski M, et al. Among authors: shealy dj. Cytokine. 1999 Jan;11(1):37-44. doi: 10.1006/cyto.1998.0389. Cytokine. 1999. PMID: 10080877

9

Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation.

Song XY, Fox F, Gallo MA, Rosenberg A, Jordan R, Shealy D, Wagner C. Song XY, et al. Among authors: shealy d. J Infect Dis. 2002 Jan 15;185(2):204-13. doi: 10.1086/338451. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807694

10

Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.

Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P. Cornillie F, et al. Among authors: shealy d, d haens g. Aliment Pharmacol Ther. 2001 Apr;15(4):463-73. doi: 10.1046/j.1365-2036.2001.00956.x. Aliment Pharmacol Ther. 2001. PMID: 11284774 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page